Dimensional Fund Advisors LP Neurocrine Biosciences Inc Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 684,439 shares of NBIX stock, worth $93.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

684,439

Previous 615,636 11.18%

Holding current value

$93.5 Million

Previous $68.1 Million 26.34%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$87.54 - $128.18 $6.02 Million - $8.82 Million	68,803 Added 11.18%	684,439 $86 Million
Q1 2025 May 13, 2025	BUY	$107.22 - $153.29 $7.02 Million - $10 Million	65,479 Added 11.9%	615,636 $68.1 Million
Q4 2024 Feb 13, 2025	BUY	$111.62 - $139.44 $2.96 Million - $3.7 Million	26,525 Added 5.07%	550,157 $75.1 Million
Q3 2024 Nov 07, 2024	BUY	$114.58 - $153.15 $5.81 Million - $7.77 Million	50,703 Added 10.72%	523,632 $60.3 Million
Q2 2024 Aug 09, 2024	BUY	$130.86 - $143.19 $19.4 Million - $21.2 Million	147,907 Added 45.51%	472,929 $65.1 Million
Q1 2024 May 10, 2024	SELL	$130.4 - $143.74 $1.5 Million - $1.66 Million	-11,514 Reduced 3.42%	325,022 $44.8 Million
Q4 2023 Feb 07, 2024	BUY	$106.07 - $132.76 $626,555 - $784,213	5,907 Added 1.79%	336,536 $44.3 Million
Q3 2023 Nov 09, 2023	SELL	$94.02 - $117.1 $520,400 - $648,148	-5,535 Reduced 1.65%	330,629 $37.2 Million
Q2 2023 Aug 09, 2023	BUY	$89.53 - $104.87 $1.4 Million - $1.64 Million	15,682 Added 4.89%	336,164 $31.7 Million
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $2.17 Million - $2.83 Million	-23,028 Reduced 6.7%	320,482 $32.4 Million
Q4 2022 Feb 09, 2023	SELL	$106.72 - $127.06 $1.5 Million - $1.78 Million	-14,029 Reduced 3.92%	343,510 $41 Million
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $227,682 - $266,721	2,474 Added 0.7%	357,539 $38 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $4.74 Million - $6.26 Million	-62,539 Reduced 14.98%	355,065 $34.6 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $8.51 Million - $11.1 Million	117,422 Added 39.12%	417,604 $39.1 Million
Q4 2021 Feb 09, 2022	BUY	$79.65 - $106.22 $973,721 - $1.3 Million	12,225 Added 4.25%	300,182 $25.6 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $1.46 Million - $1.68 Million	16,925 Added 6.24%	287,957 $27.6 Million
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $1.26 Million - $1.44 Million	14,090 Added 5.48%	271,032 $26.4 Million
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $241,780 - $329,663	2,761 Added 1.09%	256,942 $25 Million
Q4 2020 Feb 25, 2021	BUY	$86.91 - $108.33 $22.1 Million - $27.5 Million	254,181 New	254,181 $24.4 Million

Others Institutions Holding NBIX

# of Institutions

657

Shares Held

101M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Neurocrine Biosciences Inc Transaction History